title: Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease.
authors.forename: Serdal
authors.initials: S
authors.lastname: Ugurlu
authors.forename: Didar
authors.initials: D
authors.lastname: Ucar
authors.forename: Emire
authors.initials: E
authors.lastname: Seyahi
authors.forename: Gulen
authors.initials: G
authors.lastname: Hatemi
authors.forename: Sebahattin
authors.initials: S
authors.lastname: Yurdakul
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053583:Interleukin-1beta; C541220:canakinumab